Int. J. Mol. Sci. 2012, 13(10), 12287-12314; doi:10.3390/ijms131012287
Review

Phosphoproteomics and Lung Cancer Research

1email and 2,* email
Received: 8 August 2012; in revised form: 14 September 2012 / Accepted: 19 September 2012 / Published: 26 September 2012
(This article belongs to the Special Issue Advances in Molecular Oncology)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Massive evidence suggests that genetic abnormalities contribute to the development of lung cancer. These molecular abnormalities may serve as diagnostic, prognostic and predictive biomarkers for this deadly disease. It is imperative to search these biomarkers in different tumorigenesis pathways so as to provide the most appropriate therapy for each individual patient with lung malignancy. Phosphoproteomics is a promising technology for the identification of biomarkers and novel therapeutic targets for cancer. Thousands of proteins interact via physical and chemical association. Moreover, some proteins can covalently modify other proteins post-translationally. These post-translational modifications ultimately give rise to the emergent functions of cells in sequence, space and time. Phosphoproteomics clinical researches imply the comprehensive analysis of the proteins that are expressed in cells or tissues and can be employed at different stages. In addition, understanding the functions of phosphorylated proteins requires the study of proteomes as linked systems rather than collections of individual protein molecules. In fact, proteomics approaches coupled with affinity chromatography strategies followed by mass spectrometry have been used to elucidate relevant biological questions. This article will discuss the relevant clues of post-translational modifications, phosphorylated proteins, and useful proteomics approaches to identify molecular cancer signatures. The recent progress in phosphoproteomics research in lung cancer will be also discussed.
Keywords: lung cancer; mass spectrometry; phosphoproteomics; post-translational modification; signaling pathway
PDF Full-text Download PDF Full-Text [314 KB, uploaded 19 June 2014 04:27 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

López, E.; Cho, W.C.S. Phosphoproteomics and Lung Cancer Research. Int. J. Mol. Sci. 2012, 13, 12287-12314.

AMA Style

López E, Cho WCS. Phosphoproteomics and Lung Cancer Research. International Journal of Molecular Sciences. 2012; 13(10):12287-12314.

Chicago/Turabian Style

López, Elena; Cho, William C. S. 2012. "Phosphoproteomics and Lung Cancer Research." Int. J. Mol. Sci. 13, no. 10: 12287-12314.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert